Table 9. Serious adverse events by trial arm.
Serious Adverse Event | VL | CD4 | Total |
Relationship with HIV | |||
Definitively not related | 79 (51.3%) | 98 (54.1%) | 177 (52.8%) |
Probably not related | 18 (11.7%) | 28 (15.5%) | 46 (13.7%) |
Possibly related | 15 (9.7%) | 19 (10.5%) | 34 (10.1%) |
Probably related | 14 (9.1%) | 20 (11.0%) | 34 (10.1%) |
Definitively related | 28 (18.2%) | 16 (8.8%) | 44 (13.1%) |
Total | 154 | 181 | 335 |
Relationship with ARV | |||
Definitively not related | 100 (64.9%) | 117 (64.6%) | 217 (64.8%) |
Probably not related | 10 (6.5%) | 29 (16.0%) | 39 (11.6%) |
Possibly related | 16 (10.4%) | 20 (11.0%) | 36 (10.7%) |
Probably related | 20 (13.0%) | 11 (6.1%) | 31 (9.3%) |
Unknown | 8 (5.2%) | 4 (2.2%) | 12 (3.6%) |
Total | 154 | 181 | 335 |